PamelaACyrusMD
Neurology • West Haven, CTVIce President and Head of Global Medical Governance Bayer Healthcare Pharmaceuticals
Dr. Cyrus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bayer
400 Morgan Lane
West Haven, CT 06516Phone+1 203-812-2094
Education & Training
Boston University Medical CenterResidency, Neurology, 1990 - 1993
Marshall University School of MedicineInternship, Internal Medicine, 1989 - 1990- Marshall University Joan C. Edwards School of MedicineClass of 1989
Certifications & Licensure
MA State Medical License 1993 - 2025
Publications & Presentations
PubMed
- 8 citationsTime to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.Ira W. Klimberg, Gerald Shockey, Howard Ellison, Freida Fuller-Jonap, Richard Colgan
Current Medical Research and Opinion. 2005-07-07 - 18 citationsRandomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The...John P. Blass, Pamela A. Cyrus, Florian Bieber, Barbara Gulanski
Alzheimer Disease and Associated Disorders. 2000-01-01 - 71 citationsThe Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease PatientsMurray A. Raskind, Pamela A. Cyrus, Bianca B. Ruzicka, Barbara Gulanski
The Journal of Clinical Psychiatry. 1999-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
